Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 76,526 | 55,019 | 45,572 | -26,268 | -55,579 |
| Depreciation Amortization | 110,885 | 109,418 | 89,247 | 89,733 | 89,911 |
| Income taxes - deferred | -6,958 | 13,351 | -5,828 | -6,800 | -1,038 |
| Accounts receivable | 18,863 | -38,064 | 5,087 | 3,155 | -10,328 |
| Other Working Capital | -84,562 | -62,750 | 79,979 | 5,817 | -26,201 |
| Other Operating Activity | 43,463 | 82,307 | 6,293 | 94,101 | 125,100 |
| Operating Cash Flow | $158,217 | $159,281 | $220,350 | $159,738 | $121,865 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,984 | -116,148 | -72,041 | -73,313 | -101,768 |
| Net Acquisitions | -25,192 | N/A | 9,000 | N/A | -3,000 |
| Investing Cash Flow | $-57,176 | $-116,148 | $-63,041 | $-73,313 | $-104,768 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 45,000 | 15,000 | 671 | -50,727 | 2,272 |
| Debt Issued | N/A | 347,780 | 0 | 0 | N/A |
| Debt Repayment | -13,125 | -266,853 | -61,654 | -42,683 | -21,342 |
| Common Stock Issued | 12,016 | 13,445 | 40,340 | 32,997 | 18,373 |
| Common Stock Repurchased | -175,000 | -160,000 | -100,000 | N/A | -60,984 |
| Other Financing Activity | -99 | 0 | 0 | 0 | -943 |
| Financing Cash Flow | $-131,208 | $-50,628 | $-120,643 | $-60,413 | $-62,624 |
| Exchange Rate Effect | -1,873 | -3,323 | 3,939 | -1,571 | -12 |
| Beginning Cash Position | 169,351 | 180,169 | 139,564 | 115,123 | 160,662 |
| End Cash Position | 137,311 | 169,351 | 180,169 | 139,564 | 115,123 |
| Net Cash Flow | $-32,040 | $-10,818 | $40,605 | $24,441 | $-45,539 |
| Free Cash Flow | |||||
| Operating Cash Flow | 158,217 | 159,281 | 220,350 | 159,738 | 121,865 |
| Capital Expenditure | -48,758 | -118,961 | -74,799 | -76,135 | -102,405 |
| Free Cash Flow | 109,459 | 40,320 | 145,551 | 83,603 | 19,460 |